Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$915,136
-$115,400 QoQ
Shares Held
38,004
+3.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,378
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONETARY MANAGEMENT GROUP INC holds $39,611,391 across 9 Drug Manufacturers - General names. PFE ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,775 | $17,721,579 | |
| 2 | ABBV |
AbbVie Inc.
|
35,105 | $8,833,822 | |
| 3 | AMGN |
Amgen Inc
|
13,171 | $4,769,482 | |
| 4 | JNJ |
Johnson & Johnson
|
17,045 | $4,328,918 | |
| 5 | MRK |
Merck & Co., Inc.
|
15,685 | $2,015,522 | |
| 6 | PFE |
Pfizer Inc
This page
|
38,004 | $915,136 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,850 | $798,037 | |
| 8 | NVS |
Novartis AG
|
1,259 | $197,310 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $915,136 | 38,004 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,030,536 | 36,700 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $936,240 | 37,600 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,076,530 | 42,250 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $951,420 | 39,250 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $969,255 | 38,250 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $988,242 | 37,250 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,338,475 | 46,250 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,316,459 | 47,050 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $1,269,562 | 45,750 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,127,157 | 39,151 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,282,053 | 38,651 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,403,963 | 38,276 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,594,300 | 39,076 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,058,618 | 40,176 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,832,493 | 41,876 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,195,558 | 41,876 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,174,391 | 42,001 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,332,534 | 39,501 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,804,312 | 41,951 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,307,983 | 33,401 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,222,798 | 33,751 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,246,092 | 33,852 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,233,192 | 33,602 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,098,786 | 33,602 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $726,304 | 22,252 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||